{"doi":"10.1007/s11926-013-0405-4","title":"Management of Recurrent Thrombosis in Antiphospholipid Syndrome","abstract":null,"journal":"Current Rheumatology Reports","year":2014,"id":604638,"datarank":1.8668237358269846,"base_score":3.828641396489095,"endowment":3.828641396489095,"self_citation_contribution":0.5742962094733643,"citation_network_contribution":1.2925275263536202,"self_endowment_contribution":0.5742962094733643,"citer_contribution":1.2925275263536202,"corpus_percentile":null,"corpus_rank":null,"citation_count":45,"citer_count":42,"citers_with_citation_signal":32,"citers_with_endowment":32,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1551416,"name":"Laura Andreoli","orcid":null,"position":1,"is_corresponding":false},{"id":1551417,"name":"Cinzia Casu","orcid":null,"position":2,"is_corresponding":false},{"id":1551418,"name":"Angela Tincani","orcid":null,"position":3,"is_corresponding":false},{"id":511280,"name":"Cecilia Nalli","orcid":"0000-0003-2514-9891","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Management of Recurrent Thrombosis in Antiphospholipid Syndrome","abstract":"One of the challenges of managing patients with antiphospholipid syndrome is the prevention of rethrombosis (secondary prophylaxis). Risk stratification, i.e. traditional cardiovascular and thrombosis risk factors, systemic autoimmune diseases, antiphospholipid antibody profile, and the intensity of anticoagulation are all relevant to the management of APS patients with recurrent thrombosis. The paper will review \"state of the art\" strategies for optimizing therapy for APS patients with recurrent thrombosis.","is_dataset_classified":null,"base_score":3.828641396489095,"endowment":3.828641396489095,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"24449256","pmcid":null,"openalex_id":"https://openalex.org/W2054416239","authors":[],"funders":[],"total_grants":0,"fwci":2.9961,"citation_percentile":0.90534533,"influential_citations":0,"citation_trend":[{"year":2014,"count":3},{"year":2015,"count":3},{"year":2016,"count":5},{"year":2017,"count":2},{"year":2018,"count":5},{"year":2019,"count":3},{"year":2020,"count":3},{"year":2021,"count":2},{"year":2022,"count":4},{"year":2023,"count":6},{"year":2024,"count":4},{"year":2025,"count":5}],"oa_status":"closed","license":"http://www.springer.com/tdm","oa_locations":[{"url":"http://link.springer.com/content/pdf/10.1007/s11926-013-0405-4.pdf","host_type":"publisher"},{"url":"http://link.springer.com/article/10.1007/s11926-013-0405-4/fulltext.html","host_type":"publisher"},{"url":"http://link.springer.com/content/pdf/10.1007/s11926-013-0405-4","host_type":"publisher"},{"url":"https://doi.org/10.1007/s11926-013-0405-4","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/24449256","host_type":"repository"},{"url":"http://hdl.handle.net/11379/458147","host_type":"repository"}],"fields_of_study":["Systemic Lupus Erythematosus Research","Platelet Disorders and Treatments","Heparin-Induced Thrombocytopenia and Thrombosis","Antibodies, Antiphospholipid","Anticoagulants","Antiphospholipid Syndrome","Biomarkers","Humans","Risk Factors","Secondary Prevention","Thrombosis"],"mesh_terms":["Anticoagulants","Humans","Risk Factors","Thrombosis","Biomarkers","Antiphospholipid Syndrome","Antibodies, Antiphospholipid","Secondary Prevention"],"keywords":["Medicine","Antiphospholipid syndrome","Thrombosis","Internal medicine","Rheumatology","Risk stratification","Intensive care medicine"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-07-30T00:34:06.997034Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}